Literature DB >> 35251334

A mesorectal incidentaloma: Rare localization of Castleman disease (Case report).

Daniel Ion1,2, Alexandra Bolocan1,2, Alexandru George Filipescu1,3, Octavian Andronic1,2, Ana-Maria Oproiu1,4, Adelina Popa5, Dan Nicoale Păduraru1,2.   

Abstract

Incidentalomas are defined as tumors or pseudo-tumoral masses accidentally discovered during clinical and imaging investigations. We present a 51-year-old female patient who presented at the gynecology service for genital bleeding caused by uterine fibromatosis. Computerized pelvic tomography showed an engorged uterus completely deformed by numerous intramural and submucosal nodular structures suggestive of multiple fibroids. Behind the uterus, a well-defined, iodophilic, 49/51 mm diameter, tissue-shaped, nodular mass was identified, with pushing borders into the adjacent fat and showing a mass effect on the rectum against which it retained a demarcation zone. A conclusion of the histopathological examination was made. Histopathological aspects and immunohistochemical tests supported the diagnosis of Castleman disease (CD) variant vascular hyaline variant. The mesorectum is a particularly and extremely rare localization for CD, and preoperative diagnosis is difficult to achieve. The correct surgical attitude in the case of an incidental finding in this localization is the extensive resection that satisfies the presumption of a neoplastic formation.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  Castleman disease; fibromatosis; incidentaloma; mesorectal tumor; mesorectum

Year:  2022        PMID: 35251334      PMCID: PMC8892622          DOI: 10.3892/etm.2022.11194

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  27 in total

1.  Complete remission with anti-CD20 therapy for unicentric, non-HIV-associated, hyaline-vascular type, Castleman's disease.

Authors:  Fadi F Estephan; M Tarek Elghetany; Madonna Berry; Dennie V Jones
Journal:  Cancer Invest       Date:  2005       Impact factor: 2.176

2.  The burden of incidental findings in clinical practice in a tertiary care center.

Authors:  Aspasia Soultati; Alexandra Alexopoulou; Spyridon P Dourakis; Helen Dimopoulou; Panayiotis Katsaounis; Demosthenes Cokkinos; Athanasios J Archimandritis
Journal:  Eur J Intern Med       Date:  2010-01-27       Impact factor: 4.487

3.  Use of a claims database to characterize and estimate the incidence rate for Castleman disease.

Authors:  Nikhil Munshi; Maneesha Mehra; Helgi van de Velde; Avinash Desai; Ravi Potluri; Jessica Vermeulen
Journal:  Leuk Lymphoma       Date:  2014-09-29

4.  Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.

Authors:  A R Keller; L Hochholzer; B Castleman
Journal:  Cancer       Date:  1972-03       Impact factor: 6.860

Review 5.  Incidentaloma: from general practice to specific endocrine frame.

Authors:  Ancuta Augustina Gheorghisan-Galateanu; Mara Carsote; Ana Valea
Journal:  J Pak Med Assoc       Date:  2017-06       Impact factor: 0.781

Review 6.  Treatment of Idiopathic Castleman Disease.

Authors:  Frits van Rhee; Amy Greenway; Katie Stone
Journal:  Hematol Oncol Clin North Am       Date:  2018-02       Impact factor: 3.722

Review 7.  Diagnosis of Castleman Disease.

Authors:  Raphaël Szalat; Nikhil C Munshi
Journal:  Hematol Oncol Clin North Am       Date:  2018-02       Impact factor: 3.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.